NCT02807376

Brief Summary

This prospective, randomized, controlled, multi-center study will collect and compare data from the surgeon's current standard of care stapler (for renal artery and renal vein transection) and powered vascular stapler

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 21, 2016

Completed
14 days until next milestone

Study Start

First participant enrolled

July 5, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 23, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 23, 2017

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

December 19, 2018

Completed
Last Updated

December 19, 2018

Status Verified

November 1, 2018

Enrollment Period

1.1 years

First QC Date

June 14, 2016

Results QC Date

August 21, 2018

Last Update Submit

November 29, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of Vessels Transected Requiring Intra-Operative Hemostatic Interventions

    Proportion of hemostatic interventions/procedures completed for intra-operative bleeding related to the transection of the Reanl Artery and Renal Vein during laparoscopic nephrectomy or nephroureterectomy with the use of standard of care stapler (SOC) or powered vascular stapler (PVS) defined as bleeding detected and controlled intraoperatively (additional stapling, over-sewing, clip placement, compression, use of suture, sealant, and/or buttress, and/or use of energy); or bleeding that occurs intra-operatively requiring blood or blood product transfusion or an additional surgical procedure (e.g. conversion to open).

    Intra-Operative, an average of 2.6 hours, ranging from 42 minutes to 6.4 hours

Secondary Outcomes (1)

  • Proportion of Participants Requiring Post-operative Interventions or Procedures Related to Renal Artery or Renal Vein Bleeding

    Post-Op through 4 Week Follow-up

Study Arms (2)

Surgeon's 'standard of care' stapler

ACTIVE COMPARATOR

Surgeon's standard of care stapler

Device: Surgeon's 'standard of care' stapler

Ethicon Powered Vascular Stapler

EXPERIMENTAL

Ethicon Powered Vascular Stapler

Device: Ethicon Powered Vascular Stapler

Interventions

Surgeon's 'standard of care' stapler
Ethicon Powered Vascular Stapler

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for a simple or radical laparoscopic nephrectomy or a laparoscopic nephroureterectomy in accordance with the institution's standard of care (SOC);
  • Performance status 0-1 (Eastern Cooperative Oncology Group classification), if applicable;
  • American Society of Anesthesiologists (ASA) score \< 3;
  • No prior history of partial or wedge nephrectomy (on the kidney in which the procedure will be performed);
  • Willing to give consent and comply with study-related evaluation and treatment schedule; and
  • At least 18 years of age

You may not qualify if:

  • Prior chemotherapy or radiation (within 30 days prior to the procedure or the duration of the subject's enrollment);
  • Pregnancy;
  • Physical or psychological condition which would impair study participation; or
  • The subject is judged unsuitable for study participation by the Investigator for any other reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University

Atlanta, Georgia, 30322, United States

Location

Results Point of Contact

Title
Michael Schwiers
Organization
Ethicon

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2016

First Posted

June 21, 2016

Study Start

July 5, 2016

Primary Completion

August 23, 2017

Study Completion

August 23, 2017

Last Updated

December 19, 2018

Results First Posted

December 19, 2018

Record last verified: 2018-11

Locations